last week of the quarter, page-18

Starpharma will have 29 million plus dollars in bank end of March quarter.

The company did a CR in December quarter 2015, Starpharma had 23 - 24 million in bank at time of raising.

In hindsight, it can be seen that raising was needed. If not, today, the company would have run out of cash.

Several months ago, I laughed when some posters suggested a further CR would be required.

Several months ago, I was so confident we would have by now - be "in the money" with BV Gel formulation monetized.

Several months ago, I was so confident we would have now completed DEP Docetaxel phase 1 clinical trial.

It has not materialised as of yet.

The CR is needed now to shore up starpharma share price.

The company does not need money yet

However better to be safe than sorry. Be sure as soon as a deal has been done, by June quarter 2017, a CR will occur.

And to all those that think, I have run out of patience.

Wrong - plenty up my sleeve